# Vaccine Against Atherosclerosis in Patients With Overweight Problems or Obesity

> **NCT03042741** · PHASE3 · UNKNOWN · sponsor: **Immunitor LLC** · enrollment: 300 (estimated)

## Conditions studied

- Atherosclerosis

## Interventions

- **BIOLOGICAL:** atherosclerosis vaccine
- **BIOLOGICAL:** Placebo pills

## Key facts

- **NCT ID:** NCT03042741
- **Lead sponsor:** Immunitor LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-02-01
- **Primary completion:** 2019-12-18
- **Final completion:** 2019-12-18
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2019-04-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03042741

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03042741, "Vaccine Against Atherosclerosis in Patients With Overweight Problems or Obesity". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03042741. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*